Berdoy, M., Webster, J. P., & Macdonald, D. W. (2000). Fatal attraction in rats infected with Toxoplasma gondii. Proceedings of the Royal Society (London), B267, 1691-1594.
Brown, A. S., Schaefer, C. A., Quesenberry Jnr, C. P., Lui, L., Babulas, V. P., & Susser, E. S. (2005). Maternal exposure to Toxoplasmosis and risk of schizophrenia in adult offspring. American Journal of Psychiatry, 162(4), 767-773.
Dubey, J. P. (1999). The scientific basis for prevention of Toxoplasma gondii infection. In P. Ambroise-Thomas, & E. Petersen, (Eds.). Congenital Toxoplasmosis: Scientific background, clinical management and control (pp. 271-276). New York: Springer.
Flegr, J., Havlicek, J., Kodym, P., Marek, M., & Zbynek, S. (2002). Increased risk of traffic accidents in subjects with latent Toxoplasmosis: A retrospective case-control study. BMC Infectious Diseases, 2(11), 6. Retrieved May 31, 2006, from Ovid.
Frenkel, J. K. (1999). Biology of Toxoplasma gondii. In P. Ambroise-Thomas, & E. Petersen (Eds.), Congenital Toxoplasmosis: Scientific background, clinical management and control (pp. 9-20). New York: Springer.
Gilbert, R. E., & Stanford, M. R. (2000). Is ocular Toxoplasmosis caused by prenatal or postnatal infection? British Journal of Ophthalmology, 84, 224-226.
Hayde, M., & Pollack, A. (1999). Clinical Picture: Neonatal signs and symptoms. In P. Ambroise-Thomas & E. Petersen (Eds.), Congenital Toxoplasmosis: Scientific background, clinical management and control (pp. 153-164). New York: Springer.
Holland, G. N., Muccioli, C., Silveira, C., Weisz, J. W., Belfont, R. Jun., & O’Connor, G.R. (1999). Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic Toxoplasmosis. American Journal of Ophthalmology, 128(4), 413-420.
Jones, J. L., Kruszon-Moran, D., & Wilson, M. (2003). Toxoplasma Gondii infection in the United States, 1999-2000. Emerging Infectious Diseases, 9(11), 1371-1374.
Jones, J. L., Lopez, A., Wilson, M., Schulkin, J., & Gibbs, R. (2001). Congenital Toxoplasmosis: A review. Obstetrical & Gynecological Survey, 56(5), 296-305.
Portugal, L. R., Fernandes, L. R., Cesar, G. C., Santiago, H. C., Oliveira, D. R., Silva, N. M., Silva, A. A., Lannes-Viera, J., Arantes, R. M. E., Gazzinelli, R. T., & Aalvarez-Leite, J. I. (2004). Infection with Toxoplasma gondii increases atherosclerotic lesion in Apo-E deficient mice. Infection and Immunity, 72(6), 3571-3576.
Rothova, A. (1999). Recurrent ocular disease in congenital Toxoplasmosis: Clinical manifestations. In P. Ambroise-Thomas & E. Petersen (Eds.), Congenital Toxoplasmosis: Scientific background, clinical management and control (pp. 215-229). New York: Springer.
Thulliez, P., & Romand, S. (1999). Prenatal screening and prevention of congenital Toxoplasmosis in France. In P. Ambroise-Thomas & E. Petersen (Eds.), Congenital Toxoplasmosis: Scientific background, clinical management and control (pp. 293-298). New York: Springer.
Ustun, U., Aksoy, U., Dagci, H., & Ersoz, G. (2004). Incidence of Toxoplasmosis in patients with cirrhosis. World Journal of Gastroenterology, 10(3), 452-454.
Vallochi, A. L., Nakamura, M. V., Schlesinger, D., Martins, M. C., Silveira, C., Belfort Jnr, R., & Rizzo, L. V. (2002). Ocular Toxoplasmosis: More than just meets the eye. Scandinavian Journal of Immunology, 55, 324-328.
Zhang, X., Li, Q., Hu, P., Cheng, H., & Huang, G. (2002). Two case reports of pituitary adenoma associated with Toxoplasma gondii infection. Journal of Clinical Pathology, 55, 965-966.